1/17/2007

A study by Prime Therapeutics found about 90% of prescriptions written for the Actiq painkiller "lollipop" are for off-label uses. Cephalon's berry-flavored lozenge on a stick is approved for cancer and AIDS patients and has potentially serious side effects.

Related Summaries